370 related articles for article (PubMed ID: 27122661)
21. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
22. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
[TBL] [Abstract][Full Text] [Related]
23. [Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression].
Kong LB; Ren WG; Mi HM; Zhao SX; Zhang YG; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):207-12. PubMed ID: 23967743
[TBL] [Abstract][Full Text] [Related]
24. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
25. Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis.
Chao X; Wang S; Hlobik M; Ballabio A; Ni HM; Ding WX
Am J Pathol; 2022 Jan; 192(1):87-103. PubMed ID: 34717896
[TBL] [Abstract][Full Text] [Related]
26. Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors.
Wieser V; Adolph TE; Enrich B; Kuliopulos A; Kaser A; Tilg H; Kaneider NC
Gut; 2017 May; 66(5):930-938. PubMed ID: 26858343
[TBL] [Abstract][Full Text] [Related]
27. The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.
Levin I; Petrasek J; Szabo G
Alcohol Clin Exp Res; 2012 Aug; 36(8):1397-406. PubMed ID: 22376231
[TBL] [Abstract][Full Text] [Related]
28. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice.
Iwasa J; Shimizu M; Shiraki M; Shirakami Y; Sakai H; Terakura Y; Takai K; Tsurumi H; Tanaka T; Moriwaki H
Cancer Sci; 2010 Feb; 101(2):460-7. PubMed ID: 19906067
[TBL] [Abstract][Full Text] [Related]
29. The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.
Li SQ; Wang DM; Zhu S; Ma Z; Li RF; Xu ZS; Han HM
Hum Exp Toxicol; 2015 Nov; 34(11):1053-72. PubMed ID: 25585999
[TBL] [Abstract][Full Text] [Related]
30. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
Toriguchi K; Hatano E; Tanabe K; Takemoto K; Nakamura K; Koyama Y; Seo S; Taura K; Uemoto S
J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-32γ attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses.
Lee DH; Kim DH; Hwang CJ; Song S; Han SB; Kim Y; Yoo HS; Jung YS; Kim SH; Yoon DY; Hong JT
Clin Sci (Lond); 2015 May; 128(10):695-706. PubMed ID: 25583360
[TBL] [Abstract][Full Text] [Related]
33. [Activation of Fas/FasL and its downstream signaling pathway promotes development of alcoholic steatohepatitis and liver fibrosis in mice].
Ren WG; Kong LB; Mi HM; Zhao SX; Zhang YG; Wang RQ; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):129-33. PubMed ID: 23663886
[TBL] [Abstract][Full Text] [Related]
34. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
[TBL] [Abstract][Full Text] [Related]
35. Dietary tomato powder inhibits alcohol-induced hepatic injury by suppressing cytochrome p450 2E1 induction in rodent models.
Stice CP; Liu C; Aizawa K; Greenberg AS; Ausman LM; Wang XD
Arch Biochem Biophys; 2015 Apr; 572():81-88. PubMed ID: 25592162
[TBL] [Abstract][Full Text] [Related]
36. STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice.
Kaltenecker D; Themanns M; Mueller KM; Spirk K; Golob-Schwarzl N; Friedbichler K; Kenner L; Haybaeck J; Moriggl R
Cytokine; 2019 Dec; 124():154573. PubMed ID: 30377054
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice.
Tornai D; Furi I; Shen ZT; Sigalov AB; Coban S; Szabo G
Hepatol Commun; 2019 Jan; 3(1):99-115. PubMed ID: 30619998
[TBL] [Abstract][Full Text] [Related]
38. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
Chen N; Nishio N; Ito S; Tanaka Y; Sun Y; Isobe K
Cancer Immunol Immunother; 2015 Jun; 64(6):777-89. PubMed ID: 25832002
[TBL] [Abstract][Full Text] [Related]
39. ¹H and ³¹P NMR lipidome of ethanol-induced fatty liver.
Fernando H; Kondraganti S; Bhopale KK; Volk DE; Neerathilingam M; Kaphalia BS; Luxon BA; Boor PJ; Shakeel Ansari GA
Alcohol Clin Exp Res; 2010 Nov; 34(11):1937-47. PubMed ID: 20682011
[TBL] [Abstract][Full Text] [Related]
40. Exercise retards hepatocarcinogenesis in obese mice independently of weight control.
Arfianti A; Pok S; Barn V; Haigh WG; Yeh MM; Ioannou GN; Teoh NC; Farrell GC
J Hepatol; 2020 Jul; 73(1):140-148. PubMed ID: 32302728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
